New CRISPR approach may open path to hepatitis E treatment by blocking viral RNA
Researchers at the Ruhr University Bochum have developed a novel antiviral concept: Using the CRISPR/Cas13 system, they were able to specifically suppress the replication of the hepatitis E virus in human cells. Hepatitis ...
May 17, 2026
0
3









